secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001213900-24-096807
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali Capital extends business combination deadline to Dec 11, 2024 with $15,064 deposit
--------------------------------------------------------------------------------

- Deposited $15,063.74 into trust account to extend deadline from Nov 11 to Dec 11, 2024.
- Funding came from a convertible promissory note issued to Scilex Holding (SCLX) for up to $180,000.
- Note bears no interest, repayable upon business combination or liquidation; convertible at $10.00/share.
- Remaining $119,772.04 under the note may fund future monthly extensions.
- SPAC (DECA) is a blank-check company seeking a business combination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390024096807/0001213900-24-096807-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390024096807/ea0220633-8k425_denali.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-096807

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer